🔗 Visit the ClinicalTrials.gov page for NCT01716039
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Infliximab for induction and maintenance therapy for ulcerative colitis. | N Engl J Med | 2005 | 14.50 |
| 2 | Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease. | N Engl J Med | 2003 | 8.49 |
| 3 | Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial. | Gut | 2011 | 6.08 |
| 4 | Adalimumab induces and maintains mucosal healing in patients with Crohn's disease: data from the EXTEND trial. | Gastroenterology | 2012 | 2.03 |